LATE BREAKING ABSTRACT: Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial

Date 26 September 2015
Event European Cancer Congress 2015
Session Presidential Session I
Topics Renal Cell Cancer
Presenter Choueiri, T.